The present invention relates to anti-microbial, antiviral, fibers, and fabrics and to devices made from said fabrics. The invention has particular utility in connection with personal protective equipment (PPE's) such as surgical masks and respirators, and will be described in connection with such utilities, although other utilities are contemplated.
Surgical masks and respirators mitigate the spread of infectious diseases including, but not limited to the common cold, influenza, SARS, H1N1 Swine Flu, and most recently, COVID-I9, also known as “coronavirus.” Surgical masks and respirators and masks are designed to reduce the spread of airborne illnesses by providing a physical filter between facial regions of the wearer's and the wearer's ambient environment. Surgical masks are less effective than respirators, which provide a tighter seal around the nose and mouth and provide better air filtration. Surgical masks are also less effective than respirators at reducing the spread of viral or other microbial infections via aerosolized particles, making them a risky form of personal protective equipment for health care providers dealing with influenza, COVID-I9, and other infectious microbes. Effective prevention of the spread of airborne illnesses is particularly important for healthcare providers and first responders, who frequently come into contact with infected and non-infected patients.
Common masks used by non-medical professionals, i.e., paper or cloth masks, which are only partially effective at reducing the spread of viral or other pathogen infection through inhalation and exhalation. Paper masks are not regulated and while they have been established as more effective than no barrier, their efficacy is variable, with only 30-50% barrier efficacy in some instances, which may provide users a false sense of security leading them to acquire or spread infection. Unregulated paper masks typically are not multi-ply and do not provide respiratory protection. Paper masks are mainly useful at preventing the user from touching the area around their nose and mouth, and are only marginally useful for preventing a patient from contracting infection or from preventing an infected patient from spreading infection. Nevertheless, for aerosolized virus, they offer better air filtration of viral pathogens than no mask at all. During times of pandemic when personal protective gear must be rationed due to high demand, the need for a continuous supply of replacement masks places financial and medical strains on the health care system.
Surgical masks are loose-fitting and disposable, and often wrap around the ears to cover just the nose and mouth. Most surgical masks are multi-ply, providing better filtration than paper and cloth or homemade masks. Some surgical masks have an additional face shield. Surgical masks are regulated, unlike cloth or paper masks, and reduce the risk of contracting or spreading infection by filtering out a degree of small particles such as viruses. Surgical masks are used by doctors, surgeons, and dentists during medical procedures for maintaining a sterile procedure and preventing fluid transmission between healthcare providers and patients. However, there is still risk of infection transfer as surgical masks have been shown to have reduced efficacy reportedly around 80% of particles for air filtration, which aids in preventing the spread of viral pathogens either via exhalation or inhalation. Surgical masks also serve as a barrier to liquid splashes including saliva. However, surgical masks do not cover eyes to prevent ocular transmission of aerosolized pathogens. Surgical masks are frequently worn in East Asian culture, including in Japan and Taiwan, to reduce the risk of spreading infection and as a sign of social responsibility to alert others that the person may be infectious.
Respirators provide further protection against bilateral spread of infection preventing the wearer from being exposed to infection and preventing an infected person from exposing others. The most common respirators are disposable N95-NI00 respirator masks. Respirators under optimal circumstances are designed to be tight-fitting around the nose and mouth area and filter out small particles including virus. Respirators, when perfectly fitting, may filter out 95%-100% of airborne particles as small as 0.3 microns. Respirators, in conjunction with other personal protective equipment are highly effective at reducing the spread of viral and bacterial pathogens and commonly used by research and medical professionals. However, there are inherent limitations of the effectiveness of the masks when used by wearers who have facial hair, who experience perspiration on the face that limits the occlusive fit of the mask, or who's facial shape does not allow a perfect or secure fit. Furthermore, in the case of COVID 19 the virus is extremely tiny (less than 0.2 microns) making an adjunctive means of anti-microbial activity in a mask more important. Additionally, as mask efficiency is increased, e.g., through use of additional or thicker or tighter layers, the pressure required to pull air through the mask is increased. Pressure also increases as the layers become loaded with particles. Filter designs which include tortuous pathways which slow particle velocity and/or trapping of particles also increase pressure. Improving the antimicrobial milieu of the breathing chamber in a mask may help overcome the limitations of an imperfect respirator and improve the antimicrobial environment of a face shield.
Furthermore, some respirators, including N95 masks, are disposable, in order to eliminate the opportunity for daily contamination when exposed to infected persons or patients, and to avoid the potential spread of infection between health care providers with each other or spreading infection between patients. It is assumed respirators become contaminated when doctors come into contact with infected patients, particularly for aerosolized types of infection—or when worn by an infected person. Unfortunately, in the event of a shortage of personal protective equipment, including face masks, healthcare providers and first responders are forced to reuse face masks, increasing the likelihood of becoming infected themselves and of spreading infection to others. Conventional respirators when worn properly by a person infected with viral, bacterial, or fungal pathogens decrease the spread of their droplets by keeping them trapped in the face cup. However, these devices do nothing to decrease the level of infectious pathogens already present on skin or viral reservoirs in an infected patients nasal or oral cavities. In fact, face masks on an infected person in some instances may actually create the moist environment that could increase viral replication.
Furthermore, face masks and respirator N-95-100 masks which are disposable and easily contaminated, require large volumes of equipment to maintain supply in times of pandemic, causing shortages and limiting public access to these items in order to necessarily maintain the health and protection of health care providers and other essential workers.
In our parent U.S. application Ser. No. 15/823,076, we describe a method for producing metal particle filled fibers by dispersing metal particles throughout the fibers during fiber production, and to metal particle filled fibers produced thereby. Preferably, the metal particles include zinc particles, zinc oxide particles, or zinc salt particles, having a particle sized range of 1 micron-200 microns. The metal filled fibers may then be used to form fabric devices for treating hyperhidrosis and other conditions such as neuropathic pain including peripheral artery disease and neuropathy; surgical rehabilitation and surgical convalescence including joint surgery, rehabilitation and soft tissue healing; and physical therapy including muscle and tendon headlong and stroke rehabilitation by applying directly onto a skin surface of a patient in need of such treatment, a device comprising a fabric or substrate containing discrete patterns of elemental zinc particles arranged so that the fabric or substrate in contact with the skin of the wearer forms a plurality of half-cells of an air-zinc battery, whereby to produce an ion exchange with the skin of the patient. Zinc, zinc oxide or zinc salt particles against the skin also will result in secondary reactions to form zinc complexes beneficial to the host. The ability to deliver topical zinc to the surface of the skin can have beneficial effects provided the zinc particles are in the correct physical arrangement.
Additionally, the therapeutic value of metals and metal salts such as zinc, zinc oxide and zinc salt in cosmetic and medicinal ointments and creams, i.e., for treating a variety of skin conditions is well documented in the art. However, one of the limitations of creams or ointments is that they require a carrier gel or petrolatum, and these carriers create barriers on the skin, potentially trapping microbes beneath the barriers.
We have now found that fibers containing discrete patterns of nano size zinc particles for forming fabrics incorporated into personal protective equipment such as masks, provide an anti-microbial kill rate in excess of 99% when in close proximity to the skin of a human or other animal. This is unexpected since micron size particles of zinc as disclosed in our aforesaid PCT application and other a prior art required that the zinc particles needed to be in contact with the skin of the wearer to generate an electrical field to have any antimicrobial effect. We have now found that by employing nano size zinc particles electrical fields are formed in the fabric even in areas not in contact with the skin of the wearer. All that is necessary is that the fabric contact the skin of the wearer at some point. While not wishing to be bound by theory, it is believed that as the zinc particles approach <1000 nanometers in size, quantum effects being to apply substantially increasing surface energies and field effects which bridge areas of the fabrics and which result in kill rates of microbes not seen with larger size particles. More particularly, we have found that fibers containing nano-size particles of zinc, preferably 1 to 1,000 nanometers, even more preferably 1 to 100 nanometers sized particles have a kill rate in excess of 99% against various microbes or pathogens, including but not limited to viruses causing the common cold, influenza, SARS, H1N1 (swine flu) and COVID-19, as well as bacteria, algae, fungi, molds, yeasts, etc. This is unexpected since larger size zinc particles incorporated into fibers do not provide similar anti-microbial properties.
Preferably the fiber material a comprises thermoplastic polymer, preferably polyethylene, although polypropylene, various thermoplastic polymer materials and natural fibers may be used. Preferably the zinc-nano particles are incorporated into the polymer fibers on formation of the fiber. However, the zinc nano particles also could be applied to the surface of the fibers using binders, or heated nano particles may be sprayed directly onto the surface of the fibers. The nano particles also may be wiped directly onto the surface of the fiber and into interstities in the fiber surface, for example by pulling the fibers through a “bath” of nano particles, or wiping the nano particles onto the fibers. The nano particles also may be printed into the surface of the fibers. In order to strengthen the fiber, carbon nanotubes may include in the fiber during fiber formation.
Further features and advantages of the present invention will be seen from the following detailed description, taken in conjunction with the accompanying drawings, wherein like numerals depict like parts, and wherein:
As used herein the term “microbe” or “pathogen”, which are used interchangeably, may include bacteria, algae, fungi, molds, yeasts, and viruses including but not limited to the common cold, influenza, SARS, H1N1, Swine Flu and COVID-19 commonly know as “Coronavirus”.
“Personal protective equipment” or PPE may include masks, scrubs, respirators, caps and other headgear such as face shields, and other types of clothing as well as sheets, pillowcases, and the like.
“Metal particles” may include elemental zinc particles and oxides and salts thereof.
“Fibers” include natural and artificial fibers, preferably thermoplastic and thermosetting fiber materials more preferably, polyethylene.
And “metal filled fibers” means fibers, having metal particles carried on or within the fibers, and in which at least some of the metal particles are at least in part exposed to air.
The present invention in one aspect provides a method forming nanosized metal particle filled fibers suitable for weaving or knitting into a fabric for use in forming personal protective equipment. More particularly, the present invention in one aspect provides a method for producing nanosized metal particle containing fibers that are capable of forming metal-air electrochemical cells, capable of releasing ions when adjacent or in contact with a wearer's skin or moisture.
The metal particle fiber matrix interacts with exhaled moisture and oxygen, or moisture and oxygen from the wearer's skin surface, and/or ambient moisture and oxygen to generate a microcurrent. An electric field is created without an external battery source, which destrous virulent microbes or pathogens including Coronavirus.
Referring to
Referring to
Referring to
Referring to
The mask 100, as illustrated in
Completing the mask are fasteners such as ear straps or head straps 120 configured to attach the mask to the head of the wearer.
The present invention is unique in that the zinc pattern grid on the tactile layer creates a matrix of individual half-cells (anodes) for ion exchange with the skin of the wearer which effectively kills microbes on or adjacent the skin of the wearer or between the skin and the tactile layer. However, the zinc pattern grid does not have to be in direct contact with the skin of the wearer. One-half cell of electrochemical reaction is the zinc impregnated fabric (the anode), and the other is the skin of the wearer, with the breath of the wearer or moisture from the skin of the wearer, supplying moisture and oxygen (the cathode) completing the circuit for microcurrent production. Alternatively, the oxygen and moisture may be supplied, in part, from ambient air.
There results a Zinc-air battery powered by oxidizing zinc with oxygen from the air. During discharge, zinc particles form a porous anode, which is saturated with an electrolyte, namely moisture from the breath or skin of the wearer or from the air. Oxygen from the air or skin of the wearer reacts at the cathode and forms hydroxyl ions which migrate into the zinc paste and form zinc hydroxide Zn(OH)2, releasing electrons to travel to the cathode. The chemical equations for the zinc-air battery formed using Applicants' zinc-coated masks and ambient oxygen are as follows:
Anode: Zn+4OH−→Zn(OH)42−+2e−(E0=−1.25 V)
Fluid: Zn(OH)42−→ZnO+H2O+2OH−
Cathode: ½O2+H2O+2e−→2OH−(E0=0.34 V)
Overall, the zinc oxygen redox chemistry recited immediately hereinabove comprises an overall standard electrode potential of about 1.59 Volts.
There is a certain amount of gas exchange at the skin surface with a partial pressure of oxygen. The oxygen at the skin surface is a product of ambient oxygen in addition to oxygen diffusion from capillary blood flow. In certain embodiments, the zinc in contact with a patient's skin or breath resulting from wearing, for example, our zinc-containing mask, in combination with moisture from the skin or breath of the wearer and transcutaneous oxygen complete the galvanic circuit described hereinabove.
The chemistry utilized by Applicants' zinc-coated mask differs from a more conventional galvanic cell. A galvanic cell, or voltaic cell is an electrochemical cell that derives electrical energy from spontaneous redox reactions taking place within the cell. It generally consists of two different metals connected by a salt bridge, or individual half-cells separated by a porous membrane. In contrast, the chemistry of Applicants' zinc-air battery does not require use of a second metal. Applicants' device acts as a powerful antimicrobial exhibiting a virus reduction or kill in excess of 99%.
The fabric is configured to contact the skin or breath of the wearer and to generate an electric current and metal ions when the metal ions bind with ambient oxygen or oxygen from the skin of the wearer. The generation of such an electric current kills microbes in the vicinity. Another added advantage is that the zinc-air battery may reduce mask rash, and zinc and oxygen are healthy for the skin.
The fabric described herein also may be used in the manufacture of various personal protective equipment such as gowns, scrubs, caps, etc., as well as various clothing items as well as sheets, pillow cases, towels, wipes, etc. that may come into contact with or close proximity to the skin.
Various changes may be made in the above invention without departing from the spirit and scope. For example, the fibers may be co-extruded to have a center or core of the same or dissimilar polymer with the metal filled polymer on the outside of the fiber. Co-extrusion has the advantage that the center of the fiber is void of metal and therefore can contribute more strength to the fiber, while the outer layer may be loaded with metal particles. Or, the metal filled polymer may be intermittently dispersed into discrete reservoirs within the fiber during fiber formation. And, of carbon fiber nanotubes (hollow-tubes) can be added to provide increased tensile strength as well as the antimicrobial nature of the hollow tubes. The carbon nanotubes also are electrically conductive and will electrically connect the zinc particles in the reservoir into a layer mass so that the available zinc ions are interconnected providing a layer capacity or discharge. Additionally, if there is a recharging effect of free floating H+ ions, then the carbon nanotubes also will enable more even recharging of the zinc mass. Also, the amount of metal particles in the fibers may be adjusted to adjust the capacity or voltage of the air battery in the thread or yarn.
This application is a continuation-in-part (CIP) of our co-pending U.S. patent application Ser. No. 17/073,261, filed Oct. 16, 2020, which in turn is a CIP of our co-pending U.S. patent application Ser. No. 15/823,076, filed Nov. 27, 2017, and also claims priority to our co-pending provisional application Ser. No. 63/090,221, filed Oct. 10, 2020, the contents of which are incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
63090221 | Oct 2020 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17073261 | Oct 2020 | US |
Child | 17110093 | US | |
Parent | 15823076 | Nov 2017 | US |
Child | 17073261 | US |